A single blinded, parallel treatment clinical study; to evaluate the efficacy and safety of Zandu Lalima Vs Topical Cream in treatment of Acne Vulgaris (pimples) and improvement in skin lightness on healthy human subjects.

EMAMI LIMITED0 个研究点目标入组 70 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Volunteer in generally good health.
•2.Volunteer between the ages of 18 to 25 years.
•3.Volunteer suffering from mild to moderate symptoms of acne vulgaris (pimples).
•4.Volunteer having regular menstrual cycles of approximately 25 to 35 days.
•5.Volunteer willing to do blood test as per study requirement.
•6.Volunteer willing for still photography.
•7.Volunteer has not participated in a similar clinical investigation in the past four weeks.
•8.Volunteer without known allergy/ sensitivity to cosmetic products or fragrance and without any skin allergies / infections.
•9.Volunteer not under any dermatologic treatment / prescribed medications.
•10.Volunteer willing to abstain from using any cosmetic product on face, besides the provided product during the entire study course.
•11.Volunteer willing to visit the site at specified frequencies for periodic evaluations.
•12.Volunteer willing to comply with study specific requirements.
•13.Volunteer willing to give a written informed consent and come for regular observation.

•1.A known history or present condition of allergic response to any cosmetic products.
•2.Skin disease except acne vulgaris (pimples) (e.g. psoriasis, atopic dermatitis or other cutaneous manifestations on the scalp), which would interfere with the test readings.
•3.Medications (e.g. steroids or antihistamines), which would compromise the study.
•4. Currently or has been undergoing dermatologist facial treatments or procedures within the last 1 month.
•5.Subject viewed by the investigator as not being able to complete the study or participating in another study.

发起方